US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.110
+0.010+0.86%

Trading Aug 26 10:10 ET

33.11MMarket Cap-508P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AN2 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

AN2 Therapeutics Earnings Reports

AN2 Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 16:21 ET

AN2 Therapeutics | 10-Q: Q1 2024 Earnings Report

May 14 16:19 ET

AN2 Therapeutics | 10-K/A: Annual report (Amendment)

May 14 16:06 ET

AN2 Therapeutics | 10-K: FY2023 Annual Report

Mar 29 16:28 ET

Analyst Rating

Updated: Aug 14, 2024

Buy

Buy
50.00%
Hold
25.00%
Sell
25.00%

Price Target

No Data

Heat List

Overall